Hepatozelluläres Karzinom

  • D. Strumberg
  • H. Wilke


Häufigkeit: Obwohl mit etwa 1–2% eine vergleichsweise seltene maligne Erkrankung in den USA, ist es mit 20–30% das häufigste Malignom in Teilen von Asien und Afrika


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. American Joint Committee on Cancer (1992) Liver (including intrahepatic bile ducts). In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (eds) Manual for staging of cancer. Lippincott, Philadelphia, pp 89–90Google Scholar
  2. Beghiti J, Panis Y, Farges et al. (1991) Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 241: 114–117CrossRefGoogle Scholar
  3. Carr BI (1992) High objective response rates of advanced hepatocellular carcinoma to intraarterial chemotherapy. Proc ASCO 11: 470Google Scholar
  4. Colombo M (1992) Hepatocellular carcinoma. J Hepatol 15: 225–236PubMedCrossRefGoogle Scholar
  5. Farmer DG, Rosove MH, Shaked A, Busuttil RW (1994) Current treatment modalities for hepatocellular carcinoma. Ann Surg 219: 236–247PubMedCrossRefGoogle Scholar
  6. Franco D, Capussotti L, Smadja C et al. (1990) Resection of hepatocellular carcinoma. Gastroenterology 98: 733–738PubMedGoogle Scholar
  7. Gastrointestinal Tumor Study Group (1990) A prospective trial of recombinant human interferon alpha 2b in previously untreated patients with hepatocellular carcinoma. Cancer 66: 135–139CrossRefGoogle Scholar
  8. Hochster HS, Green MD, Speyer S (1985) 4-Epidoxorubicin (epirubicin) activity in hepatocellular carcinoma. J Clin Oncol 3: 1525–1540Google Scholar
  9. Ikeda K, Saitoh S, Tsubota A et al. (1993) Risk factor for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 71: 19–25PubMedCrossRefGoogle Scholar
  10. Iwatsuki S, Starzl TE, Sheahan DA (1991) Hepatic resections versus transplantation for hepatocellular carcinoma. Ann Surg 214: 221–229PubMedCrossRefGoogle Scholar
  11. Lotze MT, Flickinger JC, Carr BI (1993) Hepatobiliary neoplasms. In: DeVita VT, Hellman S, Rosenberg (eds) Cancer principles and practice of oncology. Lippincott, Philadelphia, pp 883–900Google Scholar
  12. Nagorney DM, Van Heerden JA, Illstrup DM, Adson MA (1989) Primary hepatic malignancy: Surgical management and determinants of survical. Surgery 106: 740–749Google Scholar
  13. Okuda K, Ohtsuki T, Obata H (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 Patients. Cancer 56: 918–928PubMedCrossRefGoogle Scholar
  14. Okuda K (1992) Hepatocellular carcinoma: recent progress. Hepatology 15: 948–963PubMedCrossRefGoogle Scholar
  15. Pichlmayr R, Weimann A, Steinhoff G, Ringe B (1992) Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol 31 [suppl I]: 157–161CrossRefGoogle Scholar
  16. Stone MJ, Klintmalm G, Polter D et al. (1989) Neo-adjuvant chemotherapy and orthotopic liver transplantation for hepatocellular carcinoma. Transplantation 48: 344–347PubMedCrossRefGoogle Scholar
  17. Takayasu K, Moriyama N, Muramatsu Y et al. (1990) The diagnosis of small hepatocellular carcinomas: efficiency of various imaging procedures in 100 patients. Am J Radiol 155: 49–54Google Scholar
  18. Tanaka K, Nakamura S, Numata K et al. (1992) Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology 185: 457–460PubMedGoogle Scholar
  19. Yamanaka N, Okamoto E, Foyasaka A (1990) Prognostic faktors after hepatectomy for hepatocellular carcinoma. Cancer 56: 1104–1110CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • D. Strumberg
  • H. Wilke

There are no affiliations available

Personalised recommendations